Role of B cell activating factor in non-infectious complications of common variable immunodeficiency

Project Details

Description

Project Narrative Common variable immunodeficiency (CVID) is the most common symptomatic primary immunodeficiency. Approximately 50% of CVID patients develop autoimmune and lymphoproliferative complications, which are the greatest cause of morbidity and mortality because there are no effective treatments. This work will study the cytokine B cell activating factor and its relationship with the B cell maturation arrest that defines CVID in order to understand why these complications occur in the hope of inspiring novel therapeutic approaches.
StatusFinished
Effective start/end date12/02/1831/01/23

Funding

  • National Institute of Allergy and Infectious Diseases: $188,676.00
  • National Institute of Allergy and Infectious Diseases: $188,676.00
  • National Institute of Allergy and Infectious Diseases: $190,299.00
  • National Institute of Allergy and Infectious Diseases: $188,676.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.